isoflurophate has been researched along with Cystic Fibrosis in 4 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "4-methylumbelliferylguanidinobenzoate (MUGB) reactivity in plasma from patients with cystic fibrosis and in amniotic fluid from pregnancies leading to children with cystic fibrosis, has been reported to be significantly decreased." | 7.66 | A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis. ( Schwartz, M, 1982) |
| "4-methylumbelliferylguanidinobenzoate (MUGB) reactivity in plasma from patients with cystic fibrosis and in amniotic fluid from pregnancies leading to children with cystic fibrosis, has been reported to be significantly decreased." | 3.66 | A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis. ( Schwartz, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrere, J | 1 |
| Grataroli, R | 1 |
| Marfin, J | 1 |
| Ferrua, B | 1 |
| Thouvenot, JP | 1 |
| Figarella, C | 1 |
| Schwartz, M | 1 |
| Costello, CM | 1 |
| McQuaid, K | 1 |
| O'Connor, CM | 1 |
| Fitzgerald, MX | 1 |
| Conover, JH | 1 |
| Conod, EJ | 1 |
| Hirschhorn, K | 1 |
4 other studies available for isoflurophate and Cystic Fibrosis
| Article | Year |
|---|---|
Non-competitive enzyme immunoassay of human trypsin 1.
Topics: Adult; Animals; Binding, Competitive; Cystic Fibrosis; Humans; Immunoenzyme Techniques; Infant, Newb | 1983 |
A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis.
Topics: Amniotic Fluid; Cystic Fibrosis; Endopeptidases; Female; Humans; Hymecromone; Isoflurophate; Pregnan | 1982 |
Effect of the addition of protease inhibitors to sputa from cystic fibrosis patients.
Topics: alpha 1-Antitrypsin; Aminocaproic Acid; Cystic Fibrosis; Edetic Acid; Ethylmaleimide; Humans; Isoflu | 1994 |
Studies on ciliary dyskinesia factor in cystic fibrosis. IV. Its possible identification as anaphylatoxin (C3a)-IgG complex.
Topics: Aminocaproates; Animals; Biological Assay; Blood Coagulation Factors; Carboxypeptidases; Cell Line; | 1974 |